Stay updated on AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.

Latest updates to the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe record history shows a new revision tag v3.6.2 replacing the previous v3.6.0, signaling an update to the study record history.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe record history now shows recruitment is closed ('No longer looking for participants'), indicating enrollment has ended. The revision tag has been updated to v3.6.0, replacing the old v3.5.5.SummaryDifference0.7%

- Check25 days agoChange DetectedThe study record version history now shows Revision: v3.5.5, replacing the previous v3.5.4. This indicates an updated page revision in the system without altering the underlying study data.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision label, v3.5.4, has been added to the study record history, replacing the previous v3.5.3. This indicates an updated version of the record is now current.SummaryDifference0.1%

- Check68 days agoChange DetectedUpdated the site footer “Revision” label on the record history page from v3.5.2 to v3.5.3. This reflects a platform/version change rather than any modification to the underlying trial record history.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.